beta-lipotropin, gln(9)- has been researched along with deferoxamine in 1 studies
| Studies (beta-lipotropin, gln(9)-) | Trials (beta-lipotropin, gln(9)-) | Recent Studies (post-2010) (beta-lipotropin, gln(9)-) | Studies (deferoxamine) | Trials (deferoxamine) | Recent Studies (post-2010) (deferoxamine) |
|---|---|---|---|---|---|
| 48 | 0 | 24 | 6,703 | 240 | 1,266 |
| Protein | Taxonomy | beta-lipotropin, gln(9)- (IC50) | deferoxamine (IC50) |
|---|---|---|---|
| Lysine-specific demethylase 4A | Homo sapiens (human) | 3.275 | |
| Deoxyhypusine hydroxylase | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hubmann, G; Lütz, S; Rosenthal, K; Schwarz, J | 1 |
1 other study(ies) available for beta-lipotropin, gln(9)- and deferoxamine
| Article | Year |
|---|---|
Triaging of Culture Conditions for Enhanced Secondary Metabolite Diversity from Different Bacteria.
Topics: Bacillus amyloliquefaciens; Culture Media; Data Mining; Deferoxamine; Genome; Lysine; Microbial Sensitivity Tests; Multigene Family; Myxococcales; Oligopeptides; Rhodococcus; Secondary Metabolism; Streptomyces | 2021 |